Particle.news

Download on the App Store

ACIP Shifts COVID Vaccine Guidance to Shared Decision-Making, Preserves Coverage

The reconstituted panel replaced a blanket COVID recommendation with shared decision-making to preserve access.

Overview

  • Advisers voted unanimously to recommend shared clinical decision-making for COVID vaccination for everyone 6 months and older, and HHS said the move maintains coverage across public and private insurers.
  • A proposal to require prescriptions for COVID shots failed after a 6–6 split was broken by Chair Martin Kulldorff voting no.
  • Members asked CDC to add stronger language on risks and uncertainties to vaccine information statements and to emphasize individualized risk–benefit discussions.
  • Child guidance changes included favoring separate MMR and varicella shots for children under 4; a vote on delaying the newborn hepatitis B dose was tabled, and universal hepatitis B testing in pregnancy won unanimous support.
  • The recommendation is broader than the FDA’s narrower authorizations for older and high‑risk groups; most private insurers plan to keep covering shots through 2026, some states are issuing their own access guidance, and the votes await sign‑off by acting CDC director Jim O’Neill.